Found 31 resultsAuthor [ Title] Type Year
Filters: Author is Carter, S [Clear All Filters]
Ability of minority patients to find donors from an ethnically diverse cord blood bank. presented at the 2002.. (2002).
Antigen-Specific T-Lymphocyte Function After Cord Blood Transplantation. Biol Blood Marrow Transplant, 12, 1335-1342. presented at the 12/2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17162216. (2006).
Blood and Marrow Transplant Clinical Trials Network (BMT CTN): Addressing Unanswered Questions. Biol Blood Marrow Transplant, 13, 257-262. presented at the 03/2007. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17317578. (2007).
Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant, 11, 571-575. presented at the 08/2005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16041306. (2005).
Characteristics of CD34-Enriched Products Processed at Multiple Centers Using the CliniMACS System - BMT CTN 0303 (Abstract). In 16th Annual ISCT (International Society for Cellular Therapy) Meeting. presented at the 2010, Philadelphia.. (2010).
Characteristics of CliniMACS® System CD34-Enriched T Cell-Depleted Grafts in a Multicenter Trial for Acute Myeloid Leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303. Biol Blood Marrow Transplant, 18, 690-697. presented at the 05/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21875505. (2012).
Developing Materials for Transplant Centers to Share BMT CTN Clinical Trial Results with their Patients: A Pilot Study (Poster). In NCI ASCO Cancer Trials Accrual Symposium. presented at the 2010, Bethesda, MD. Retrieved from http://university.asco.org/CT2010. (2010).
Development of an Accrual Assessment Tool for BMT CTN Transplant Trials: A Proactive Approach. In NCI ASCO Cancer Trials Accrual Symposium Poster Session. presented at the 29/04/2010, Bethesda, MD. Retrieved from http://university.asco.org/CT2010. (2010).
Economic Analysis of Unrelated Allogeneic Bone Marrow Transplantation: Results From The Randomized Clinical Trial of T-Cell Depletion vs Unmanipulated Grafts for the Prevention of Graft-Versus-Host Disease. Bone Marrow Transplant, 36, 539-546. presented at the 09/2005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16044144. (2005).
Economic analysis of unrelated allogeneic bone marrow transplantation: results from the randomized clinical trial of T-cell depletion vs unmanipulated grafts for the prevention of graft-versus-host disease. Bone Marrow Transplant, 36(6), 539-46. presented at the 2005 Sep. doi:10.1038/sj.bmt.1705078. (2005).
The Effect of Unrelated Donor Marrow Transplantation on Health-Related Qualify of Life: A Report of the Unrelated Donor Marrow Transplantation Trial (T-cell Depletion Trial). Biol Blood Marrow Transplant, 12, 648-655. presented at the 06/2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16737938. (2006).
Etanercept, Mycophenolate, Denileukin, or Pentostatin Plus Corticosteroids for Acute Graft-Versus-Host Disease: A Randomized Phase 2 Trial from the Blood and Marrow Transplant Clinical Trials Network. Blood, 114, 511-517. presented at the 07/2009. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19443659. (2009).
Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol, 8(12), 1930-41. presented at the 1997 Dec.. (1997).
Impact of transfusions and acute rejection on post-transplant donor antigen-specific responses in two study populations. Transplantation, 67, 697-702. presented at the 1999.. (1999).
Impact of transfusions and acute rejection on posttransplantation donor antigen-specific responses in two study populations. Cooperative Clinical Trial in Transplantation Research Group. Transplantation, 67(5), 697-702. presented at the 1999 Mar 15. doi:10.1097/00007890-199903150-00009. (1999).
Maximizing Accrual to Transplant Trials in Multiple Myeloma (MM): Lessons from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), Eastern Cooperative Oncology Group (ECOG) and Cancer and Leukemia Group B (CALGB) Collaboration (Poster). In NCI ASCO Cancer Trials Accrual Symposium. presented at the 2010, Bethesda, MD.. (2010).
One-Unit Versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers. N Engl J Med, 371, 1685-1694. presented at the 10/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25354103. (2014).
Optimizing Donor Selection for Public Cord Blood Banking: Influence of Maternal, Infant, and Collection Characteristics On Cord Blood Unit Quality. Transfusion, 54, 340-352. presented at the 02/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23711284. (2014).
Peripheral-Blood Stem Cells Versus Bone Marrow from Unrelated Donors. N Engl J Med, 367, 1487-1496. presented at the 10/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23075175. (2012).
A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results from CALGB 100103/BMT CTN 0502. In 54th Annual ASH Meeting. presented at the 08/12/2012, Atlanta, GA. Retrieved from http://www.hematology.org/Meetings/Annual-Meeting/. (2012).
Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: A grading algorithm versus blinded expert panel review. Biol Blood Marrow Transplant, 9, 512-8. presented at the 2003.. (2003).
Randomized Double-blind Trial of Fluconazole vs Voriconazole for Prevention of Invasive Fungal Infection after Allo Hematopoietic Cell Transplantation. Blood, 116, 5111-5118. presented at the 12/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20826719. (2010).
Results of the Cord Blood Transplantation Study (COBLT): Clinical Outcomes of Unrelated Donor Umbilical Cord Blood Transplantation in Pediatric Patients with Inborn Errors of Metabolism. In 2005 ASBMT Tandem BMT Meetings. presented at the 02/2005, Keystone, CO.. (2005).